Web Name: Company






Our vision: Bring individualised treatment decisions to all patients diagnosed with skin cancer

NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer.
The tests provide actionable, tumor-specific information for each individual patient. The information is used to make improved treatment decisions, i.e. whether therapy is absolutely necessary or whether a patients' survival estimate is so favourable that it is reasonable to avoid drug therapy and the associated, severe side effects.

Through its partnerships with pharmaceutical companies and leading investigators, NeraCare is at the forefront of designing cutting-edge clinical trials to help expand access to drugs for early stage patients.
NeraCare's initial focus is a quantitative RT-PCR-based assay – MELAGENIX (derived from "melanoma" & "genetics") – which complements conventional risk assessment (i.e. AJCC staging) and helps make individualized, therapeutic decisions for melanoma patients. The intended use is in stage I-III patients.

NeraCare recently acquired Synvie (now a subsidiary), the developer ofa second, immunohistochemistry-based test – immunoprint – with focus on changing the treatment algorithm for patients diagnosed with very early stage melanoma.

Further products for non-melanoma skin cancers are currently under development.


Dr. Matthias Ackermann

Chief Executive Officer


A seasoned entrepreneur, investor and veteran of the oncology industry (ex-Amgen; previous exit to Alliance Boots / KKR), Matthias has experience of founding and scaling companies up to €400m revenue.


Daniel von Janowski

Chief Strategy Officer,

Chief Financial Officer


A previous M&A investment banker with Evercore Inc., Daniel studied Mechanical Engineering & Management at TU Darmstadt and the London School of Economics. He co-founded NeraCare's Sydney office before joining the management team.


Younes Salahdine

Chief Operating Officer


With experience in M&A investment banking and operations at Deutsche Bank and multiple startups, Younes helped build the international offices (AUS/USA) at NeraCare. He studied Computer Science & Management at TU Darmstadt and Finance at WHU.


Dr. Anton Strobel

Chief Executive Officer

Synvie(subsidiary of NeraCare)

A Physician and pharma marketing specialist, Anton is founder, investor and CEO of Synvie; he previously co-founded medical services specialist MEDITEL.


Petra Toepker

Chief Operating Officer

Synvie(subsidiary of NeraCare)

A special needs educator by training, Petra has around 20 years experience in operations, team and project management.



Dr. Matthias Kromayer

General Partner & Executive @ MIG AG

A biologist by training, Matthias has over 20 years of experience in healthcare and pharmaceutical strategy and investments. He has been part of MIG Verwaltungs AG since 2010.


Dr. Peter Graf

Investment Manager @ BayBG

A molecular biologist by training, Peter worked as a Research Scientist at Max Planck Institute. He has been a life science investor with BayBG since 2018, focusing on digital health, deep tech, diagnostics and biotech ventures.


Friedrich Ackermann

Managing Director @ A18i Capital

A previous management consultant at McKinsey & Company and M&A banker at Morgan Stanley, Friedrich has been shaping NeraCare's strategy since its foundation. He studied at Harvard University and the London School of Economics.


Dr. Helge Lubenow

CEO @ Proteomedix AG

Helge is CEO of Proteomedix AG which develops biomarker signatures for prostate cancer diagnostics. She previously spent 18 years at Qiagen in R&D and commercial roles and serves on the boards of epigenomics, tesa labtec and evorion biotechnologies.



Phone: +49 (69) 2731595-00
NeraCare GmbHEschenheimer Anlage 26D-60318 Frankfurt
Managing directors:
Dr. Matthias Ackermann, Daniel von Janowski
Imprint Copyright 2020 © All Rights reserved. Share by:


<<< Thank you for your visit >>>

Websites to related :
Spark Networks SE | A global lea

  Skip to main navigation Logo

Artichoke Dance Company


Toronto Custom Signs: signs Toro

  .a{fill:url(#a);}.b{fill:#fff;}416-903-9444HomeIndoor SignsOutdoor SignsCustom SignsBusiness SignsVinyl SignsBlogsContact UsMenuHomeIndoor SignsOutdoo

Multicom is a software vendor co

  HomeAbout UsAbout UsBlogNewsServicesSolutionsBilling &#038; Revenue ManagementCustomer ManagementData &#038; AnalyticsBusiness Process ManagementFinan

Best Digital Marketing


Incubate | A Shopify App develop

   Toggle navigation

Home | Ash Grove North Cement Co

  Aller au contenuNous trouverRessourcesPortail clientEnglishFrançaisMenu principalProduction et distributionProduits et servicesNos projetsEnvironneme

Key Resin Company

   search Professional&#39;s Toolbox

Multiplex - a leading global con

  ContentSearchNavigationSitemapGlobalSearchMenuHome60 YearsAbout usAbout us overview Our brand story Leadership Locations Responsible business (5)Respo

Home - Forcine Concrete & Constr

   CompanyServicesProjectsCareers Contact


Hot Websites